ClearPoint® Navigation System to be used for all enrolled patients in Aspen's ASPIRO Parkinson's cell therapy clinical trial
Newly Launched ClearPoint Neuro technology - SmartFrame OR and Prism Laser will be on display at ASSFN in Nashville from June 1 - 4
Q1-2024 Revenue Growth +41%, a Company Record
Novel drug delivery research to be presented by ClearPoint Neuro Biologics team at ASGCT 2024 Annual Meeting in Baltimore
FDA Clearance of Prism Bone Anchor Accessory will expand use of the ClearPoint Prism® Neuro Laser Therapy to Operating Room
First 10 operating room procedures with SmartFrame OR successfully completed. Company expects positive impact to revenue in 2024 due to OR expansion.
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global device, cell, and gene therapy-enabling company offering precise navigation...
ClearPoint Neuro's partner's completed BLA Submission for Upstaza„ would be first disease-modifying treatment for AADC Deficiency in the US.
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
Journal of Neurosurgery Publication Shows Advantage of ClearPoint Therapy System